What is Integra LifeSciences's other long-term liabilities?

Integra LifeSciences (IART) reported other long-term liabilities of $369K in Q1 2026.

How has Integra LifeSciences's other long-term liabilities changed year-over-year?

Integra LifeSciences's other long-term liabilities decreased by 73.4% year-over-year, from $1.39M to $369K.

What is the long-term trend for Integra LifeSciences's other long-term liabilities?

Over 2 years (2021 to 2025), Integra LifeSciences's other long-term liabilities has grown at a 10.3% compound annual growth rate (CAGR), from -$14.11M to -$17.16M.

Integra LifeSciences IART Other long-term liabilities

Other long-term liabilities at other companies

Alphatec HoldingsATEC

——

Other financials

Income statement

See full

Revenue$391.9M+2.4%

Gross profit$217.0M+11.6%

Operating income$11.5M+174%

Net income-$4.6M+81.7%

EPS (diluted)-$0.06+81.8%

Balance sheet

See full

Cash & equivalents$236.8M-1.0%

Total debt$2.0B+3.2%

Total equity$1.0B-31.6%

Total assets$3.6B-11.7%

Cash flow

See full

Operating cash flow$9.8M+187%

CapEx$14.8M-48.7%

Free cash flow-$5.0M+87.4%

Valuation

See full

Market cap$1.38B-56.8%

Enterprise value$3.12B-26.7%

P/S0.8×-1.1×

Profitability

See full

Gross margin51.9%-1.6pp

Operating margin-29.8%-30.3pp

Net margin-30.1%—

FCF margin3.8%-6.3pp

Returns & leverage

See full

Return on equity-38.6%—

Debt / equity1.9×+0.6×

Current ratio3.4×+2.2×

Where this comes from

Reported directly by Integra LifeSciences in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities.

The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integra LifeSciences's other long-term liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Integra LifeSciences's other long-term liabilities?: Integra LifeSciences (IART) reported other long-term liabilities of $369K in Q1 2026.
How has Integra LifeSciences's other long-term liabilities changed year-over-year?: Integra LifeSciences's other long-term liabilities decreased by 73.4% year-over-year, from $1.39M to $369K.
What is the long-term trend for Integra LifeSciences's other long-term liabilities?: Over 2 years (2021 to 2025), Integra LifeSciences's other long-term liabilities has grown at a 10.3% compound annual growth rate (CAGR), from -$14.11M to -$17.16M.